drugset / Trial / NCT03198767

Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066

NCT03198767

Phase 2 Completed 54 enrolled Novartis Pharmaceuticals
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study was to determine if LIK066 taken with a meal containing low carbohydrate is associated with less diarrhea compared to a high carbohydrate meal and to assess the potential effects of supplements such as psyllium or calcium carbonate on alleviating diarrhea associated with LIK066.

Timeline

Start
2017-06-21
Primary completion
2017-09-04
Completion
2017-09-04

Drugs

EvaluationDrugModalityDoseRoute
Subject licogliflozin Small molecule 50 mg

Indications